Načítá se...
Pharmacological Treatment of Alzheimer’s Disease: Is it Progressing Adequately?
INTRODUCTION: Between 1993 and 2000 four acetylcholinesterase inhibitors were marketed as a symptomatic treatment for Alzheimer’s disease (AD), as well as memantine in 2003. Current research is focused on finding drugs that favorably modify the course of the disease. However, their entrance into the...
Uloženo v:
| Hlavní autor: | |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Bentham Open
2009
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2684708/ https://ncbi.nlm.nih.gov/pubmed/19461897 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1874205X00903010027 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|